Boehringer Ingelheim strong growth pipeline acceleration 2023 | Boehringer Ingelheim
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
HSSPs improve medication adherence and reduce total health care costs by directly managing medications for complex chronic conditions like cancer, diabetes, COPD and CHF.
Study finds race-based disparities in offering empathy, communicating medical information
Michael Morse, MD, FACP, MHS, medical oncologist at Duke Cancer Center, explained the importance of managing toxicities in the changing hepatocellular carcinoma (HCC) treatment landscape…
The Agency for Healthcare Research and Quality (AHRQ) Making Healthcare Safer (MHS) reports consolidate information for healthcare providers, health system administrators, researchers, and government agencies…
The purpose of this systematic review was to document and summarize reported barriers and facilitators to the receipt of selected clinical preventive services among people…
March 2024 R. Henry Olaisen, Ph.D., M.P.H., P.M.P., and Marc Roemer, M.S. Prior to the COVID-19 pandemic, 95 percent of all emergency department (ED) visits…
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
Use of digital healthcare technologies – for clinicians and patients – is growing. To ensure these solutions benefit all patient groups, creators and users must be…